Holding(s) in Company

RNS Number : 5192E

Verona Pharma PLC

08 May 2017


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:		Verona Pharma plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:	Growth Equity Opportunities IV, LLC
4. Full name of shareholder(s) (if different from 3.):
5. Date of the transaction and date on which the threshold is crossed or reached:	May 2, 2017
6. Date on which issuer notified:	May 5, 2017
7. Threshold(s) that is/are crossed or reached:	8% to 9% change at direct interest level

8. Notified details:

A: Voting rights attached to shares

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights

Direct

Indirect

Direct

Indirect

Ordinary Shares

GB00B06GSH43

4,424,065

4.47%

US9250501064

5,333,328

5.39%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date

Exercise/
Conversion Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instrument

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date

Exercise/
Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

9,757,393

9.86%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
Growth Equity Opportunities IV, LLC is a limited liability company formed in the State of Delaware, United States New Enterprise Associates 15, L.P., a limited partnership formed in the State of Delaware, is its sole member NEA Partners 15, L.P., a limited partnership formed in the State of Delaware, is its general partner NEA 15 GP, LLC, a limited liability company formed in the State of Delaware, is its general partner

Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:	Figures are based on a total number of 99,014,164 Ordinary Shares outstanding, as per the Company's Announcement of May 2, 2017.
14. Contact name:	Louis Citron, New Enterprise Associates
15. Contact telephone number:	+1 (410) 842-4000

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUGUBPAUPMGQR